合計 46 件の最近のインサイダー取引記録が記録されています Spyre Therapeutics, Inc. (SYRE), 内訳は 28 件の買い および 16 件の売り. インサイダー買い総額は $70.86M インサイダー売り総額は $8.01M.
最近活動のある主要インサイダーには Turtle Cameron, Burrows Scott L, Sloan Sheldon. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — SYRE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-01 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
2,656 |
$49.92 |
$132.59K |
627,540 |
| 2026-04-01 |
Burrows Scott L |
Chief Financial Officer |
情報に基づく売り |
1,300 |
$49.98 |
$64.97K |
97,994 |
| 2026-04-01 |
Sloan Sheldon |
Chief Medical Officer |
情報に基づく売り |
7,958 |
$50.00 |
$397.9K |
- |
| 2026-03-03 |
Burrows Scott L |
Chief Financial Officer |
情報に基づく売り |
200 |
$41.66 |
$8.33K |
97,994 |
| 2026-03-02 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
9,100 |
$42.49 |
$386.66K |
642,540 |
| 2026-02-02 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
14,043 |
$32.87 |
$461.59K |
657,540 |
| 2026-01-21 |
Henderson Michael Thomas |
Director |
その他（買い） |
63,227 |
- |
- |
168,606 |
| 2026-01-09 |
Turtle Cameron |
Chief Executive Officer |
RSU 付与（制限付株式） |
528,000 |
$30.61 |
$16.16M |
528,000 |
| 2026-01-09 |
King-jones Heidy |
See Remarks |
RSU 付与（制限付株式） |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Burrows Scott L |
Chief Financial Officer |
RSU 付与（制限付株式） |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Sloan Sheldon |
Chief Medical Officer |
RSU 付与（制限付株式） |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-02 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
100 |
$32.39 |
$3.24K |
671,907 |
| 2025-12-01 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
4,005 |
$29.83 |
$119.47K |
686,907 |
| 2025-11-03 |
Turtle Cameron |
Chief Executive Officer |
情報に基づく売り |
16,845 |
$23.66 |
$398.55K |
701,907 |
| 2025-09-02 |
Burrows Scott L |
Chief Financial Officer |
情報に基づく売り |
18,428 |
$16.26 |
$299.64K |
97,994 |
| 2025-05-29 |
Albers Jeffrey W. |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Stelzer Laurie |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Mckenna Mark C. |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Henderson Michael Thomas |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Fairmount Funds Management Llc |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Milligan Sandra |
Director |
RSU 付与（制限付株式） |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-01-15 |
Turtle Cameron |
Chief Executive Officer |
RSU 付与（制限付株式） |
370,000 |
$21.66 |
$8.01M |
370,000 |
| 2025-01-15 |
King-jones Heidy |
See Remarks |
RSU 付与（制限付株式） |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Burrows Scott L |
Chief Financial Officer |
RSU 付与（制限付株式） |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Sloan Sheldon |
Chief Medical Officer |
RSU 付与（制限付株式） |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-10 |
Henderson Michael Thomas |
Director |
その他（買い） |
105,379 |
- |
- |
105,379 |
| 2024-11-06 |
Albers Jeffrey W. |
Director |
情報に基づく売り |
6,700 |
$36.76 |
$246.31K |
27,360 |
| 2024-10-25 |
Albers Jeffrey W. |
Director |
情報に基づく売り |
300 |
$36.43 |
$10.93K |
34,060 |
| 2024-10-01 |
Sloan Sheldon |
Officer |
不明 |
- |
- |
- |
- |
| 2024-10-01 |
Sloan Sheldon |
Chief Medical Officer |
RSU 付与（制限付株式） |
400,000 |
$27.46 |
$10.98M |
400,000 |
| 2024-09-03 |
Burrows Scott L |
Chief Financial Officer |
情報に基づく売り |
18,531 |
$28.17 |
$522.07K |
116,422 |
| 2024-05-14 |
Albers Jeffrey W. |
Director |
RSU 付与（制限付株式） |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Stelzer Laurie |
Director |
RSU 付与（制限付株式） |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Henderson Michael Thomas |
Director |
RSU 付与（制限付株式） |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Fairmount Funds Management Llc |
Director |
RSU 付与（制限付株式） |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Milligan Sandra |
Officer |
不明 |
- |
- |
- |
- |
| 2024-05-14 |
Milligan Sandra |
Director |
RSU 付与（制限付株式） |
21,980 |
$39.29 |
$863.59K |
21,980 |
| 2024-04-25 |
Fairmount Funds Management Llc |
Director |
オプション行使（売却） |
90,992 |
- |
- |
346,045 |
| 2024-02-15 |
Turtle Cameron |
Chief Executive Officer |
RSU 付与（制限付株式） |
400 |
$9.82 |
$3.93K |
746,907 |
| 2024-02-01 |
Turtle Cameron |
Chief Executive Officer |
RSU 付与（制限付株式） |
277,750 |
$25.86 |
$7.18M |
277,750 |
| 2024-02-01 |
King-jones Heidy |
See Remarks |
RSU 付与（制限付株式） |
63,000 |
$25.86 |
$1.63M |
63,000 |
| 2024-02-01 |
Burrows Scott L |
Chief Financial Officer |
RSU 付与（制限付株式） |
70,000 |
$25.86 |
$1.81M |
70,000 |
| 2024-02-01 |
Mckenna Mark C. |
Director |
処分 |
477,000 |
$10.39 |
$4.96M |
- |
| 2024-02-01 |
Mckenna Mark C. |
Director |
RSU 付与（制限付株式） |
40,000 |
$25.86 |
$1.03M |
40,000 |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
その他（売り） |
3,435,480 |
- |
- |
- |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
RSU 付与（制限付株式） |
16,667 |
- |
- |
16,667 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
